PT-141 10MG

SKU: PT141-10MG   |   Category: Research Compounds

Bremelanotide | Cyclic heptapeptide MC3R/MC4R agonist | Melanocortin research | ≥99% purity

PT-141 (Bremelanotide, cyclo-[Nle4-D-Phe7]-alpha-MSH) is a cyclic heptapeptide derived from Melanotan II via hydrolysis of the C-terminal amide to a carboxylic acid. It is a non-selective melanocortin receptor agonist with binding affinity at MC1R, MC3R, MC4R, and MC5R, with primary research interest focused on MC4R signaling in the CNS, particularly hypothalamic and limbic circuits.

Research applications include melanocortin receptor activation and selectivity profiling, MC4R-mediated cAMP and MAPK signaling studies, comparative binding assays versus alpha-MSH, Melanotan II, and selective MC3R/MC4R pharmacological tools, and investigation of melanocortin system neuromodulation in reward and motivation circuits. PT-141’s distinct C-terminal chemistry relative to Melanotan II provides a useful structure-activity reference point.

10mg lyophilized per vial. Manufactured in ISO 9001 certified, GMP-compliant facilities. Purity independently verified at ≥99% by HPLC via ISO/IEC 17025 accredited laboratory. Full COA available.

Storage: Store lyophilized at -20°C, protected from light. Reconstituted: 4°C, use within 28 days.

⚠ For laboratory research use only. Not for human or animal consumption.